Finance

Lists
Why is SVA down 4.17%?
Dive Deeper
SVA:TSE
Sernova Biotherapeutics Inc
CA$0.12
-4.17%
(-0.0050) 1D
Oct 8, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Open
CA$0.12
High
CA$0.12
Low
CA$0.11
Mkt. cap
43.58M
Avg. vol.
351.79K
Volume
42.56K
52-wk high
CA$0.20
52-wk low
CA$0.08
EPS
-CA$0.03
Beta
32.05
Shares outstanding
377.64M
No. of employees
8
Open
CA$0.12
High
CA$0.12
Low
CA$0.11
Mkt. cap
43.58M
Avg. vol.
351.79K
Volume
42.56K
52-wk high
CA$0.20
52-wk low
CA$0.08
EPS
-CA$0.03
Beta
32.05
Shares outstanding
377.64M
No. of employees
8
News stories
From web sources and news partners
About Sernova Biotherapeutics Inc
CEOJonathan Rigby
Employees8
Founded2006
HeadquartersLondon, Ontario, Canada
SectorBiotechnology
Websitesernova.com
Last report
Sep 10, 2026
Fiscal period
Q3 2026
-CA$0.01 / -CA$0.00
-100.00%miss
Revenue / Est. (CAD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
809.63K
434.15K
444.87K
432.62K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.59M
1.68M
1.85M
1.69M
Operating expense
2.40M
2.12M
2.30M
2.12M
Total operating expenses
2.40M
2.12M
2.30M
2.12M
Operating income
-2.40M
-2.12M
-2.30M
-2.12M
Other non operating income
-
-
-
-
EBT including unusual items
-2.25M
-2.41M
-3.23M
-2.57M
EBT excluding unusual items
-2.26M
-2.41M
-3.23M
-2.57M
Income tax expense
-54.97K
-72.00K
-
-45.00K
Effective tax rate
2.44%
2.99%
-
1.75%
Other operating expenses
-
-
-
-
Net income
-2.20M
-2.33M
-3.23M
-2.53M
Net profit margin
-
-
-
-
Earnings per share
-0.01
-0.01
-0.01
-0.01
Interest and investment income
260.60K
-
413.00
-
Interest expense
-
-477.12K
-920.95K
-260.18K
Net interest expenses
260.60K
-477.12K
-920.53K
-260.18K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.34M
-2.11M
-2.29M
-2.11M
Gain or loss from assets sale
-4.25K
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps